Published works by Arnold & Porter

Published works

• Recent updates on reform of UK clinical trial landscape

  BioSlice Blog · April 22, 2025

  LEX-WK-3ZK64KYQ
• UK Prime Minister Announces that NHS England will be abolished

  BioSlice Blog · March 14, 2025

  LEX-WK-98FT7TMK
• EU announces pilot coordinated assessment for clinical investigations of medical devices

  BioSlice Blog · March 11, 2025

  LEX-WK-24N1A6B3
• Virtual and Digital Health Digest – February 2025

  BioSlice Blog · February 26, 2025

  LEX-WK-Y33GYAFQ
• The new UK Innovative Licensing and Access Pathway – relaunched, refined, refreshed

  BioSlice Blog · February 4, 2025

  LEX-WK-QMXH6PAF
• Virtual and Digital Health Digest – January 2025

  BioSlice Blog · January 31, 2025

  LEX-WK-SF63VDSM
• New Year Update: incoming changes to UK regulation of clinical trials

  BioSlice Blog · January 13, 2025

  LEX-WK-DGNQRN4S
• New Year, New UK-Wide Licensing Regime

  BioSlice Blog · January 7, 2025

  LEX-WK-N73Q7BDQ
• Virtual and Digital Health Digest – December 2024

  BioSlice Blog · December 30, 2024

  LEX-WK-S6QVX1JT
• The European Commission launches public consultation on the MDR and IVDR

  BioSlice Blog · December 19, 2024

  LEX-WK-2772AF9W
• Windsor Agreement changes to UK Assimilated SPC Regulation

  BioSlice Blog · December 3, 2024

  LEX-WK-GQ7H7C9A
• Virtual and Digital Health Digest – November 2024

  BioSlice Blog · November 26, 2024

  LEX-WK-EZXMJKZJ
• EU looks to facilitate development of “orphan” medical devices

  BioSlice Blog · November 22, 2024

  LEX-WK-5MQHYM8E
• The UK Innovative Licensing and Access Pathway (ILAP) to enter a new era

  BioSlice Blog · November 21, 2024

  LEX-WK-58HZ3TTE
• The Convergence of Life Sciences and Artificial Intelligence: Seizing Opportunities While Managing Risk

  BioSlice Blog · November 13, 2024

  LEX-WK-YAX4JXE6
• UK Government Publishes Draft Regulations on Medical Devices Post-Market Surveillance

  BioSlice Blog · November 8, 2024

  LEX-WK-27HTXR66
• UK to implement novel framework for point of care manufacture of medicinal products

  BioSlice Blog · October 31, 2024

  LEX-WK-7J82QSBB
• Virtual and Digital Health Digest – October 2024

  BioSlice Blog · October 25, 2024

  LEX-WK-08RCSY84
• European Parliament resolution on need to revise the Medical Devices Regulation

  BioSlice Blog · October 24, 2024

  LEX-WK-61R5F3ZQ
• EMA adopts reflection paper on the use of Artificial Intelligence (AI)

  BioSlice Blog · October 3, 2024

  LEX-WK-VRNYQ4J2
• Virtual and Digital Health Digest – September 2024

  BioSlice Blog · September 26, 2024

  LEX-WK-EXJGK6XV
• AI: EMA publishes guiding principles on the use of large language models (LLMs)

  BioSlice Blog · September 20, 2024

  LEX-WK-ZJX92X26
• The European AI office and other resources relevant to high risk AI systems

  BioSlice Blog · August 29, 2024

  LEX-WK-C0HCT4WH
• Virtual and Digital Health Digest – August 2024

  BioSlice Blog · August 27, 2024

  LEX-WK-89SSRW35
• The EU AI Act: Impact on the Life Sciences Industry

  BioSlice Blog · August 7, 2024

  LEX-WK-2242NCP7